Fecal Calprotectin (Stool) at Dr. Essa Lab

Fecal Calprotectin (Stool) at Dr. Essa Lab

The Fecal Calprotectin (Stool) test at Dr. Essa Lab is a highly specialized, non-invasive diagnostic laboratory investigation used to detect and monitor inflammation within the gastrointestinal tract. Calprotectin is a calcium- and zinc-binding protein found abundantly inside neutrophilic granulocytes, representing up to 60% of their cytosolic protein content. When inflammatory processes occur in the intestinal mucosa, neutrophils migrate through the endothelial wall into the intestinal lumen. During this migration, they release calprotectin, which is subsequently excreted in the stool. Because calprotectin is remarkably stable in feces for up to seven days at room temperature and is resistant to metabolic degradation, it serves as an exceptional, highly reliable biomarker for intestinal inflammation.

This test is of paramount clinical importance in modern gastroenterology. It provides diagnostic value by helping clinicians differentiate between organic, inflammatory bowel diseases and non-inflammatory, functional bowel disorders. For years, patients presenting with chronic abdominal pain, bloating, and altered bowel habits faced immediate referral for invasive procedures. The Fecal Calprotectin test offers a reliable, cost-effective, and painless screening tool that helps determine whether invasive diagnostic procedures, such as a colonoscopy with tissue biopsy, are truly necessary. By measuring the concentration of this protein, Dr. Essa Lab provides clinicians with a clear window into the patient’s intestinal health, facilitating timely intervention, accurate monitoring, and personalized treatment strategies.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of your Fecal Calprotectin test results at Dr. Essa Lab, proper patient preparation is essential. Certain medications and dietary habits can influence the level of neutrophils in the gut, potentially leading to false-positive or false-negative outcomes. Please adhere to the following preparation guidelines:

• Medication Review: Inform your prescribing physician and the laboratory staff about all medications you are currently taking. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, naproxen, and high-dose aspirin can cause mild, temporary mucosal inflammation in the gut, leading to falsely elevated calprotectin levels. It is generally recommended to avoid these medications for at least two weeks prior to sample collection, under medical supervision.
• Proton Pump Inhibitors (PPIs): Long-term use of PPIs used to treat acid reflux may occasionally be associated with mild intestinal inflammation. Discuss with your doctor whether you need to temporarily suspend these medications.
• No Laxatives: Do not use laxatives, stool softeners, or mineral oil immediately before collecting the specimen, as they can dilute the sample and alter the concentration of calprotectin.
• Dietary Guidelines: There are no strict dietary or fasting requirements for this test. You may eat and drink normally unless otherwise instructed by your gastroenterologist.
• Active Bleeding: Avoid collecting a stool sample during periods of active hemorrhoidal bleeding, menstrual bleeding, or if you detect blood from other superficial sources, as blood contains neutrophils that can artificially elevate calprotectin levels.

During the Procedure

The Fecal Calprotectin test is entirely non-invasive and requires only a single stool specimen. The sample collection can be conveniently performed in the comfort of your home or at any Dr. Essa Lab collection center across Pakistan. Here is what you need to know about the collection process:

• Obtaining the Container: Collect a sterile, leak-proof stool specimen container provided by Dr. Essa Lab. Ensure the container is clean, dry, and free of any chemical residues.
• Sample Collection: Defecate into a clean, dry receptacle or onto a clean plastic wrap stretched over the toilet bowl. Do not allow the stool sample to come into contact with toilet water, urine, or household cleaning chemicals, as contamination will invalidate the test.
• Transferring the Specimen: Using the spatula or spoon attached to the lid of the specimen container, scoop a small portion of the stool (approximately the size of a walnut or about 5 to 10 grams) and place it inside the container. Secure the lid tightly to prevent leakage.
• Labeling and Transport: Clearly write your full name, age, gender, and the date and time of collection on the container label. Deliver the specimen to the nearest Dr. Essa Lab branch as soon as possible. If a delay of more than two hours is expected, store the sample in a refrigerator at 2 to 8 degrees Celsius, but do not freeze it.
• Laboratory Analysis: At Dr. Essa Lab, the sample is analyzed using advanced Enzyme-Linked Immunosorbent Assay (ELISA) or chemiluminescent immunoassay technology, ensuring precise quantification of calprotectin levels.

When is a Fecal Calprotectin (Stool) Test Performed?

Differentiating Inflammatory Bowel Disease (IBD) from Irritable Bowel Syndrome (IBS)

One of the primary clinical indications for this test is to distinguish between Inflammatory Bowel Disease (such as Crohn’s disease and Ulcerative Colitis) and Irritable Bowel Syndrome. IBS is a functional gastrointestinal disorder that does not cause structural damage or mucosal inflammation, resulting in normal calprotectin levels. Conversely, IBD is characterized by chronic, immune-mediated intestinal inflammation, which leads to significantly elevated calprotectin levels. This differentiation is crucial for avoiding unnecessary colonoscopies in IBS patients.

Monitoring Crohn’s Disease and Ulcerative Colitis Activity

For patients already diagnosed with Inflammatory Bowel Disease, the Fecal Calprotectin test is an invaluable tool for monitoring disease activity. Gastroenterologists frequently request this test to assess whether a patient is in clinical remission or experiencing a disease flare-up. Rising calprotectin levels often precede clinical symptoms of a relapse, allowing physicians to adjust therapeutic regimens proactively before the patient’s condition worsens.

Evaluating Unexplained Chronic Diarrhea and Abdominal Pain

Physicians routinely order a Fecal Calprotectin test when a patient presents with persistent, unexplained abdominal pain, cramping, bloating, and chronic diarrhea lasting for more than four weeks. These symptoms are common to both functional and organic gastrointestinal disorders. The test helps narrow down the differential diagnosis by confirming or ruling out active mucosal inflammation as the underlying cause of the patient’s distress.

Assessing Treatment Efficacy in Gastrointestinal Inflammation

When a patient begins a new therapeutic regimen for IBD—such as corticosteroids, immunomodulators, or biologic therapies—the Fecal Calprotectin test is used to evaluate the effectiveness of the treatment. A significant decline in calprotectin levels over time indicates a positive response to therapy and mucosal healing, whereas persistently high levels suggest that the current treatment plan may need to be modified or escalated.

Screening for Intestinal Inflammation in Pediatric Patients

In pediatric medicine, invasive endoscopic procedures are particularly challenging and carry higher risks. The Fecal Calprotectin test serves as an excellent, non-invasive first-line screening tool for children presenting with recurrent abdominal pain, growth failure, unexplained fever, or chronic diarrhea. It helps pediatric gastroenterologists determine which children require urgent endoscopic evaluation while sparing others from invasive investigations.

What Does a Fecal Calprotectin (Stool) Test Detect?

The Fecal Calprotectin test is highly sensitive to inflammatory changes in the gastrointestinal tract. A detailed analysis of the stool sample can detect, indicate, or help evaluate the following clinical findings:

• Presence of active mucosal inflammation in the small or large intestine.
• Distinction between active Inflammatory Bowel Disease (IBD) and non-inflammatory Irritable Bowel Syndrome (IBS).
• Subclinical inflammation or impending disease relapse in patients with known Crohn’s disease.
• Disease severity and inflammatory burden in patients diagnosed with Ulcerative Colitis.
• Efficacy of anti-inflammatory, immunosuppressive, or biologic therapies in restoring mucosal health.
• Mucosal healing, indicated by a return of calprotectin levels to the normal reference range.
• Gastrointestinal infections caused by bacterial pathogens (such as Salmonella, Shigella, or Campylobacter) that provoke a neutrophilic response.
• Parasitic infections of the intestinal tract that trigger localized mucosal inflammation.
• Intestinal inflammation associated with Celiac Disease or gluten-sensitive enteropathy.
• Gastrointestinal mucosal damage caused by the prolonged use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
• Presence of necrotizing enterocolitis in pediatric and neonatal populations.
• Inflammatory changes associated with diverticular disease or active diverticulitis.
• Radiation-induced enteritis or colitis following oncological radiation therapy to the pelvis or abdomen.
• Allergic colitis, particularly food protein-induced enterocolitis syndrome in infants.
• Inflammatory activity associated with colorectal polyps or large adenomas.
• Incipient inflammatory changes that may warrant further endoscopic and histopathological evaluation.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing prompt, accurate, and highly reliable diagnostic reports. The turnaround time for a Fecal Calprotectin (Stool) test is typically within 24 to 48 hours from the time the specimen is received at the main testing facility. Because this test utilizes sophisticated ELISA or automated immunoassay platforms, precise calibration and quality control checks are performed on every batch to ensure clinical accuracy.

Once your report is finalized and verified by our consultant pathologists, you will receive an automated SMS notification on your registered mobile number. Dr. Essa Lab offers multiple convenient ways to access your diagnostic reports. You can download a secure PDF version of your report directly from the official Dr. Essa Lab website by entering your patient ID and password. Alternatively, reports can be accessed via our dedicated mobile application or collected in person from any of our conveniently located diagnostic centers across Pakistan.

Fecal Calprotectin (Stool) Findings Overview

The following table outlines the general clinical interpretation of Fecal Calprotectin levels. Please note that exact reference ranges may vary slightly depending on the specific testing methodology utilized by the laboratory.

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Calprotectin Level < 50 µg/g	Normal; indicates no significant active inflammation in the gastrointestinal tract. Highly suggestive of functional disorders like IBS.	Unlikely to represent active inflammatory disease; symptoms are likely functional or extra-intestinal.
Calprotectin Level 50 – 120 µg/g	N/A	Borderline/Mild elevation. May indicate mild or early-stage inflammation, recent NSAID use, or a resolving infection. Re-testing in 4-6 weeks is often recommended.
Calprotectin Level > 120 µg/g	N/A	Elevated; indicates active organic inflammatory disease of the gastrointestinal tract. Further diagnostic workup, including endoscopy, is warranted.
Crohn’s Disease Activity	Levels < 50 µg/g indicate stable clinical and mucosal remission.	Levels > 250 µg/g indicate moderate to severe active mucosal inflammation, disease flare-up, or poor response to therapy.
Ulcerative Colitis Activity	Levels < 50 µg/g indicate quiescent disease and successful mucosal healing.	Significantly elevated levels (often > 250 µg/g) correlate with active mucosal ulceration and neutrophil infiltration.
Gastrointestinal Infections	Normal levels once the infectious pathogen has been cleared from the system.	Moderate to high elevation during acute bacterial or parasitic enteritis, resolving as the infection clears.
Drug-Induced Enteropathy	Normal levels in the absence of mucosal irritating medications.	Mild to moderate elevation due to mucosal erosions caused by chronic NSAID or PPI consumption.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Fecal Calprotectin (Stool)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified consultant pathologists, microbiologists, and experienced laboratory technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and convenience at every step of the diagnostic journey, from sample collection to report delivery.
• Quality Diagnostic Services: Dr. Essa Lab utilizes state-of-the-art automated testing platforms and adheres to strict international quality control protocols to ensure precise results.
• Professional Reporting: Our diagnostic reports are comprehensive, easy to understand, and widely accepted by leading gastroenterologists and hospitals nationwide.
• Modern Diagnostic Approach: We continuously upgrade our laboratory infrastructure to incorporate the latest advancements in molecular diagnostics and clinical chemistry.
• Comfortable Environment: All our collection centers are designed to provide a clean, hygienic, and welcoming environment for patients and their families.
• Convenient Location: With an extensive network of branches across Karachi and other major cities, finding a Dr. Essa Lab collection point near you is simple and convenient.
• Commitment to Accurate Diagnosis: Since 1987, Dr. Essa Lab has remained a trusted name in healthcare, committed to delivering accurate, timely, and affordable diagnostic services to the community.